In vivo efficacy of the recombinant anti-CD64 immunotoxin H22(scFv)-ETA′ in a human acute myeloid leukemia xenograft tumor model

Recombinant, ETA′-based CD64 immunotoxins: improved efficacy by increased valency, both in vitro and in vivo in a chronic cutaneous inflammation model in human CD64 transgenic mice

(2010) T. Ribbert et al.   BRITISH JOURNAL OF DERMATOLOGY

Current and emerging therapies for acute myeloid leukemia

(2010) Tadeusz Robak et al.   CLINICAL THERAPEUTICS

Antibody Internalization after Cell Surface Antigen Binding is Critical for Immunotoxin Development

(2009) Shu-Ru Kuo et al.   BIOCONJUGATE CHEMISTRY

Recombinant Immunotoxins Containing Truncated Bacterial Toxins for the Treatment of Hematologic Malignancies

(2009) Robert J. Kreitman   BIODRUGS

Association of MLL amplification with poor outcome in acute myeloid leukemia

(2009) Robert W. Maitta et al.   CANCER GENETICS AND CYTOGENETICS

Impact of new prognostic markers in treatment decisions in acute myeloid leukemia

(2009) Richard F Schlenk et al.   CURRENT OPINION IN HEMATOLOGY

Fcγ Receptor 1 (CD64), a Target Beyond Cancer

(2009) T. Thepen et al.   CURRENT PHARMACEUTICAL DESIGN

Immunokinases, a Novel Class of Immunotherapeutics for Targeted Cancer Therapy

(2009) Mehmet Tur et al.   CURRENT PHARMACEUTICAL DESIGN

Antibody-based therapy of leukaemia

(2009) John C. Morris et al.   EXPERT REVIEWS IN MOLECULAR MEDICINE

Small Cleavable Adapters Enhance the Specific Cytotoxicity of a Humanized Immunotoxin Directed Against CD64-positive Cells

(2009) Christian Hetzel et al.   JOURNAL OF IMMUNOTHERAPY

Antibody-Drug Conjugates for Cancer Therapy

(2008) Paul J. Carter et al.   CANCER JOURNAL

Anthracycline Cardiotoxicity: From Bench to Bedside

(2008) Luca Gianni et al.   JOURNAL OF CLINICAL ONCOLOGY

Investigating human leukemogenesis: from cell lines to in vivo models of human leukemia

(2008) J A Kennedy et al.   LEUKEMIA

Granzyme B-H22(scFv), a human immunotoxin targeting CD64 in acute myeloid leukemia of monocytic subtypes

(2008) B. Stahnke et al.   MOLECULAR CANCER THERAPEUTICS

Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia

(2008) Richard F. Schlenk et al.   NEW ENGLAND JOURNAL OF MEDICINE

An immunotoxin with greatly reduced immunogenicity by identification and removal of B cell epitopes

(2008) M. Onda et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA